Alpha Cognition (ACOG) Competitors $7.94 -0.06 (-0.75%) As of 11:38 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACOG vs. ARVN, ESPR, ORKA, ANAB, OLMA, OPT, IVA, CMPX, KOD, and ARCTShould you be buying Alpha Cognition stock or one of its competitors? The main competitors of Alpha Cognition include Arvinas (ARVN), Esperion Therapeutics (ESPR), Oruka Therapeutics (ORKA), AnaptysBio (ANAB), Olema Pharmaceuticals (OLMA), Opthea (OPT), Inventiva (IVA), Compass Therapeutics (CMPX), Kodiak Sciences (KOD), and Arcturus Therapeutics (ARCT). These companies are all part of the "pharmaceutical products" industry. Alpha Cognition vs. Its Competitors Arvinas Esperion Therapeutics Oruka Therapeutics AnaptysBio Olema Pharmaceuticals Opthea Inventiva Compass Therapeutics Kodiak Sciences Arcturus Therapeutics Arvinas (NASDAQ:ARVN) and Alpha Cognition (NASDAQ:ACOG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Is ARVN or ACOG more profitable? Alpha Cognition has a net margin of 0.00% compared to Arvinas' net margin of -19.47%. Arvinas' return on equity of -12.01% beat Alpha Cognition's return on equity.Company Net Margins Return on Equity Return on Assets Arvinas-19.47% -12.01% -6.97% Alpha Cognition N/A -80.16%-60.95% Do institutionals & insiders hold more shares of ARVN or ACOG? 95.2% of Arvinas shares are held by institutional investors. 4.7% of Arvinas shares are held by company insiders. Comparatively, 14.0% of Alpha Cognition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, ARVN or ACOG? Alpha Cognition has lower revenue, but higher earnings than Arvinas. Arvinas is trading at a lower price-to-earnings ratio than Alpha Cognition, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArvinas$372.80M1.53-$198.90M-$1.01-7.70Alpha CognitionN/AN/A-$14.64M-$1.60-4.96 Which has more volatility and risk, ARVN or ACOG? Arvinas has a beta of 2.38, indicating that its share price is 138% more volatile than the S&P 500. Comparatively, Alpha Cognition has a beta of 2.71, indicating that its share price is 171% more volatile than the S&P 500. Do analysts prefer ARVN or ACOG? Arvinas presently has a consensus price target of $16.18, suggesting a potential upside of 108.02%. Alpha Cognition has a consensus price target of $20.00, suggesting a potential upside of 151.89%. Given Alpha Cognition's stronger consensus rating and higher possible upside, analysts clearly believe Alpha Cognition is more favorable than Arvinas.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arvinas 0 Sell rating(s) 11 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.55Alpha Cognition 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor ARVN or ACOG? In the previous week, Arvinas had 22 more articles in the media than Alpha Cognition. MarketBeat recorded 23 mentions for Arvinas and 1 mentions for Alpha Cognition. Alpha Cognition's average media sentiment score of 1.89 beat Arvinas' score of 0.59 indicating that Alpha Cognition is being referred to more favorably in the news media. Company Overall Sentiment Arvinas Positive Alpha Cognition Very Positive SummaryArvinas and Alpha Cognition tied by winning 8 of the 16 factors compared between the two stocks. Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACOG vs. The Competition Export to ExcelMetricAlpha CognitionMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$128.31M$3.07B$5.65B$10.32BDividend YieldN/A2.36%5.68%4.61%P/E Ratio-4.9620.6175.6626.31Price / SalesN/A400.28521.00169.30Price / CashN/A45.9137.5661.52Price / Book3.079.7012.996.34Net Income-$14.64M-$52.73M$3.29B$270.94M7 Day Performance-7.46%1.20%-0.03%0.29%1 Month Performance2.85%6.93%4.13%6.89%1 Year PerformanceN/A19.33%69.08%29.31% Alpha Cognition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACOGAlpha Cognition2.0064 of 5 stars$7.94-0.8%$20.00+151.9%N/A$128.31MN/A-4.96N/APositive NewsARVNArvinas3.3268 of 5 stars$7.66-1.1%$19.76+158.2%-68.7%$564.22M$372.80M-7.61420News CoverageAnalyst DowngradeInsider TradeBuyback AnnouncementESPREsperion Therapeutics4.071 of 5 stars$2.77-0.5%$7.00+153.2%+47.3%$559.50M$332.31M-5.66200Gap DownORKAOruka Therapeutics2.7175 of 5 stars$14.80-3.0%$40.33+172.6%-36.0%$554.09MN/A-5.27N/AAnalyst RevisionANABAnaptysBio2.3048 of 5 stars$19.52-3.2%$46.13+136.3%-36.5%$553.70M$91.28M-4.41100Positive NewsOLMAOlema Pharmaceuticals2.7822 of 5 stars$7.88-1.6%$24.00+204.7%-33.8%$541.80MN/A-3.9970OPTOpthea0.1538 of 5 stars$3.41flat$1.33-60.9%-12.3%$524.84M$87.67K0.008Gap UpHigh Trading VolumeIVAInventiva3.1107 of 5 stars$5.40+1.6%$14.83+174.9%+153.2%$516.10M$9.20M0.00100Gap UpCMPXCompass Therapeutics2.6963 of 5 stars$3.71+0.4%$13.88+274.5%+104.1%$513.71M$850K-8.2620KODKodiak Sciences2.842 of 5 stars$9.67+3.4%$11.75+21.5%+493.5%$510.79MN/A-2.5490News CoverageAnalyst ForecastGap UpARCTArcturus Therapeutics2.8089 of 5 stars$18.31+1.0%$50.57+176.2%-5.9%$499.07M$152.31M-8.24180 Related Companies and Tools Related Companies ARVN Competitors ESPR Competitors ORKA Competitors ANAB Competitors OLMA Competitors OPT Competitors IVA Competitors CMPX Competitors KOD Competitors ARCT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACOG) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
